11 Results for "

OPM-2

" in MedChemExpress (MCE) Product Catalog:
Products (11)

11 Results for "OPM-2" in MCE Product Catalog:

8
8 Cited Publications
Cat. No.: HY-19322B
CAS No.: 1820565-69-2
Synonyms: LGH447 dihydrochloride
Target:  

Pim Apoptosis

Research Areas:  

Cancer

PIM447 dihydrochloride (LGH447 dihydrochloride) is a potent, orally available, and selective pan-PIM kinase inhibitor, with Ki values of 6, 18, and 9 pM for PIM1, PIM2, and PIM3, respectively. PIM447 dihydrochloride displays dual antimyeloma and bone-protective effects. PIM447 dihydrochloride induces apoptosis [2].
loading...
    loading...
Cat. No.: HY-149672
CAS No.: 2287186-66-5
Purity:  99.78%
Target:  

Bcl-2 Family Apoptosis

Research Areas:  

Cancer

ABBV-467 is a selective MCL-1 inhibitor (Ki: <0.01 nM). ABBV-467 induces apoptosis. ABBV-467 induces cancer cell death and inhibits tumor growth in models of hematological malignancies, such as multiple myeloma .
loading...
    loading...
Cat. No.: HY-P99430
CAS No.: 2296827-07-9
Synonyms: EM901; CC-93269

Target:  

CD3

Research Areas:  

Inflammation/Immunology Cancer

Alnuctamab (EM901) is a bispecific T-cell engager targeting BCMA and CD3, belonging to an asymmetric two-armed humanized IgG1 antibody. Alnuctamab can simultaneously bind to BCMA expressed on the surface of myeloma cells and CD3 molecules on the surface of T cells, recruiting T cells to kill tumors. Alnuctamab is used for the research of multiple myeloma. Recommend Isotype Controls: Human IgG1 kappa, Isotype Control (HY-P99001) [2] .
loading...
    loading...
Cat. No.: HY-107194
CAS No.: 102586-30-1
Purity:  99.07%
NSC12 is an orally active pan-FGF trap. NSC12 inhibits the interaction between FGF2/FGFR. NSC12 suppresses the phosphorylation of FGFR3. NSC12 reduces c-Myc levels, induces DNA damage, triggers the cleavage of Caspase 3, and promotes ROS production. NSC12 exhibits anticancer activity against lung cancer and multiple myeloma [2].
loading...
    loading...
Cat. No.: HY-146445
P300 bromodomain-IN-1 (Compoun 1u) is a potent p300 (EP300) bromodomain inhibitor with an IC50 of 49 nM. P300 bromodomain-IN-1 suppresses the expression of c-Myc and induces G1/G0 phase arrest and apoptosis in OPM-2 cells .
loading...
    loading...
Cat. No.: HY-133015
CAS No.: 2376774-73-9
Target:  

Bcl-2 Family

Research Areas:  

Cancer

Mcl-1 inhibitor 3 (compound 1) is a highly potent and orally activate macrocyclic Mcl-1 inhibitor (Ki= 0.061 nM; IC50=19 nM in an OPM-2 cell viability assay). Mcl-1 inhibitor 3 shows good pharmacokinetic properties and excellent in vivo efficacy without toxicity .
.
loading...
    loading...
Cat. No.: HY-148203
CAS No.: 1883727-31-8
Target:  

Bcl-2 Family

Research Areas:  

Cancer

Mcl-1 inhibitor 9 (example 2) is a myeloid cell leukemia 1 (Mcl-1) inhibitor with IC50 value of 0.21889 nM. Mcl-1 inhibitor 9 shows anti-tumor activity .
loading...
    loading...
Cat. No.: HY-180804
CAS No.: 3032444-06-4
CZL-077 is a potent, selective, and orally active p300/CBP bromodomain (BRD) inhibitor (p300 IC50 = 0.034 μM, CBP IC50 = 0.052 μM) exhibiting high selectivity over the BRDs of BET proteins (BRD2/3/4). CZL-077 inhibits cell growth with IC50 values of 0.024 μM and 5.6 μM in OPM-2 and 22RV1 cells, respectively. CZL-077 shows antitumor efficacy in OPM-2 and 22RV1 xenograft mouse models. CZL-077 can be used for multiple myeloma and prostate cancer research .
loading...
    loading...
Cat. No.: HY-P87278
Synonyms: hVDAC1 antibody; MGC111064 antibody; Mithocondrial porin antibody; OPM2, yeast, human complement of antibody; Outer mitochondrial membrane protein porin 1 antibody; Plasmalemmal porin antibody; Porin 31 HL antibody; Porin 31 HM antibody; Porin 31HL antibody; Porin 31HM antibody

Host:  

Rabbit

Application:  

WB

Reactivity:  

Human, Mouse, Rat

loading...
    loading...
Cat. No.: HY-181669
CAS No.: 3034595-62-2
Research Areas:  

Cancer

P300-IN-6 is an orally active histone acetyltransferase p300 HAT domain inhibitor with human IC50 values of 7 nM. P300-IN-6 suppresses c-Myc expression, decreases H3K18ac and H3K27ac levels, and inhibits cancer cell proliferation.P300-IN-6 suppresses tumor growth in xenograft mouse models.P300-IN-6 can be used for the research of multiple myeloma .
loading...
    loading...
Cat. No.: HY-181849
Research Areas:  

Cancer

MS2928 is a selective SETD8 inhibitor with an IC50 of 0.14 μM against SETD8 methyltransferase activity. MS2928 reduces cellular H4K20me1 levels and inhibits proliferation of SETD8-overexpressing multiple myeloma cells. MS2928 inhibits tumor growth in xenograft mouse models of SETD8-overexpressing multiple myeloma. MS2928 can be used for the study of SETD8 biological functions and multiple myeloma .
loading...
    loading...
  • 1